1. Introduction {#sec1-jcm-09-01484}
===============

Gallbladder cancer (GBC), which is the most common biliary tract carcinoma, has nonspecific signs and symptoms and is sometimes indistinguishable from benign disease of the gallbladder (GB) \[[@B1-jcm-09-01484]\]. Representative radiologic findings of GBC include wall thickening or mass-forming. The most common finding of radiology is wall thickening \[[@B2-jcm-09-01484]\]. However, because the GB wall may be thickened by coexisting benign disease, such as cholelithiasis, the masking of GBC can occur. In addition, these radiologic findings of GBC are not specific and may be overlapped with benign diseases of the GB, such as focal adenomyomatosis or GB polyps \[[@B2-jcm-09-01484]\]. Therefore, GBCs cannot be detected in preoperative radiologic examinations. GBCs, which are identified in the pathologic examination after cholecystectomy, are defined as incidental GBC (IGBC).

The incidence rate of IGBC after cholecystectomy was found to range up to 2.9% and this varied according to reports \[[@B3-jcm-09-01484],[@B4-jcm-09-01484],[@B5-jcm-09-01484],[@B6-jcm-09-01484],[@B7-jcm-09-01484],[@B8-jcm-09-01484],[@B9-jcm-09-01484],[@B10-jcm-09-01484],[@B11-jcm-09-01484],[@B12-jcm-09-01484],[@B13-jcm-09-01484],[@B14-jcm-09-01484],[@B15-jcm-09-01484],[@B16-jcm-09-01484],[@B17-jcm-09-01484],[@B18-jcm-09-01484],[@B19-jcm-09-01484],[@B20-jcm-09-01484],[@B21-jcm-09-01484],[@B22-jcm-09-01484],[@B23-jcm-09-01484],[@B24-jcm-09-01484],[@B25-jcm-09-01484],[@B26-jcm-09-01484],[@B27-jcm-09-01484],[@B28-jcm-09-01484],[@B29-jcm-09-01484],[@B30-jcm-09-01484],[@B31-jcm-09-01484],[@B32-jcm-09-01484],[@B33-jcm-09-01484],[@B34-jcm-09-01484],[@B35-jcm-09-01484],[@B36-jcm-09-01484],[@B37-jcm-09-01484],[@B38-jcm-09-01484],[@B39-jcm-09-01484],[@B40-jcm-09-01484],[@B41-jcm-09-01484],[@B42-jcm-09-01484],[@B43-jcm-09-01484],[@B44-jcm-09-01484],[@B45-jcm-09-01484],[@B46-jcm-09-01484],[@B47-jcm-09-01484],[@B48-jcm-09-01484],[@B49-jcm-09-01484],[@B50-jcm-09-01484],[@B51-jcm-09-01484],[@B52-jcm-09-01484],[@B53-jcm-09-01484]\]. However, IGBC may be up to 50% of all GBCs \[[@B54-jcm-09-01484]\]. GBC is the fifth most common malignant tumor of the gastrointestinal tract, with an incidence of 0.8--1.2% \[[@B55-jcm-09-01484]\]. In healthy populations, the prevalence of cholecystectomy, which is one of the most common surgeries performed, were 1.3%, 2.9%, and 11.1% in Taiwan, Brazil, and German, respectively \[[@B10-jcm-09-01484],[@B56-jcm-09-01484]\]. The different prevalences of cholecystectomy can affect the detection rate of IGBC. Cholelithiasis, which is an important cause for cholecystectomy, are affecting 10% to 15% of the adult population of developed countries \[[@B57-jcm-09-01484]\]. In the diagnosis of GBC, pathologic examinations after cholecystectomy are essential for the detection of IGBC. Cholelithiasis is the most common risk factor of GBC \[[@B5-jcm-09-01484]\]. The risk factors of IGBC include old age, female, cholelithiasis, and obesity \[[@B1-jcm-09-01484]\]. Preoperatively, the suspicious clinical and radiologic findings of IGBC are not specific, and the risk factors of IGBC and non-IGBC are overlapped \[[@B2-jcm-09-01484]\]. The performance rates of pathologic examinations after cholecystectomy may be varied according to the country and insurance policy \[[@B25-jcm-09-01484]\]. If the pathologic examinations after cholecystectomy were not performed in every case, the incidence rate of IGBC might be overestimated or underestimated. When this information for IGBC is accurate, further studies for the treatment of IGBC and predictions of the prognosis will be possible. In the present study, we aimed to elucidate the incidence rate of IGBC and the prognosis of IGBC through a meta-analysis. In addition, to obtain the clinicopathologic characteristics of IGBC, the mean age and compositions of the female ratio and pT stage were analyzed and compared to those of GBC overall.

2. Materials and Methods {#sec2-jcm-09-01484}
========================

2.1. Published Study Search and Selection Criteria {#sec2dot1-jcm-09-01484}
--------------------------------------------------

The literature search was performed using the PubMed databases through 31 July 2019. The search was performed using the following keywords: "cholecystectomy", "unsuspected or incidental", and "cancer or carcinoma or malignant or malignancy." The titles and abstracts of the searched articles were primarily screened for exclusion. Literature or systematic review articles were also screened to find additional eligible studies. The inclusion and exclusion criteria were as follows: (1) studies for the cholecystectomy by IGBCs in human samples were included and (2) non-original articles, such as case reports or review articles, were excluded.

2.2. Data Extraction {#sec2dot2-jcm-09-01484}
--------------------

For the meta-analysis, data were extracted from the eligible studies \[[@B3-jcm-09-01484],[@B4-jcm-09-01484],[@B5-jcm-09-01484],[@B6-jcm-09-01484],[@B7-jcm-09-01484],[@B8-jcm-09-01484],[@B9-jcm-09-01484],[@B10-jcm-09-01484],[@B11-jcm-09-01484],[@B12-jcm-09-01484],[@B13-jcm-09-01484],[@B14-jcm-09-01484],[@B15-jcm-09-01484],[@B16-jcm-09-01484],[@B17-jcm-09-01484],[@B18-jcm-09-01484],[@B19-jcm-09-01484],[@B20-jcm-09-01484],[@B21-jcm-09-01484],[@B22-jcm-09-01484],[@B23-jcm-09-01484],[@B24-jcm-09-01484],[@B25-jcm-09-01484],[@B26-jcm-09-01484],[@B27-jcm-09-01484],[@B28-jcm-09-01484],[@B29-jcm-09-01484],[@B30-jcm-09-01484],[@B31-jcm-09-01484],[@B32-jcm-09-01484],[@B33-jcm-09-01484],[@B34-jcm-09-01484],[@B35-jcm-09-01484],[@B36-jcm-09-01484],[@B37-jcm-09-01484],[@B38-jcm-09-01484],[@B39-jcm-09-01484],[@B40-jcm-09-01484],[@B41-jcm-09-01484],[@B42-jcm-09-01484],[@B43-jcm-09-01484],[@B44-jcm-09-01484],[@B45-jcm-09-01484],[@B46-jcm-09-01484],[@B47-jcm-09-01484],[@B48-jcm-09-01484],[@B49-jcm-09-01484],[@B50-jcm-09-01484],[@B51-jcm-09-01484],[@B52-jcm-09-01484],[@B53-jcm-09-01484]\] as follows: the first author's name, study location, study year, type of study and initial surgery, number of patients analyzed, patients' age and sex, tumor stage of IGBC, and survival rate. For the quantitative aggregation of the survival results, the correlation between IGBC and survival rate was analyzed according to the hazard ratio (HR), using one of three methods. In studies not reporting the HR or its confidence interval (CI), these variables were calculated from the presented data using the HR point estimate, log-rank statistic or its *p*-value, and the O-E statistic (the difference between the number of observed and expected events) or its variance.

If those data were unavailable, the HR was estimated using the total number of events, the number of patients at risk in each group, and the log-rank statistic or its *p*-value. Finally, if the only useful data were in the form of graphical representations of survival distributions, the survival rates were extracted at specified times to reconstruct the HR estimate and its variance under the assumption that the patients were censored at a constant rate during the time intervals. The published survival curves were evaluated independently by two authors to reduce variability. The HRs were then combined into an overall HR using Peto's method \[[@B58-jcm-09-01484]\].

2.3. Statistical Analyses {#sec2dot3-jcm-09-01484}
-------------------------

In the present meta-analysis, all data were analyzed and obtained through the Comprehensive Meta-Analysis software package (Biostat, Englewood, NJ, USA). The incidence rates of IGBC after cholecystectomy were investigated from individual studies and analyzed through a meta-analysis. We performed the subgroup analysis based on the type of initial surgery and study, and the study year. The patient's age and sex were compared between IGBC and overall GBC patients. In this meta-analysis, among fixed and random effect models, for interpretation we used the values of a random-effects model. The heterogeneity between eligible studies was assessed using Q and I^2^ statistics and presented using *p*-values. In addition, the sensitivity analysis was conducted to assess the heterogeneity of eligible studies and the impact of each study on the combined effect. Subgroup analyses were performed based on the type of initial surgery and study, the patients' age and sex, and the pT stage. The statistical significances between subgroups were evaluated through a meta-regression test. To consider the publication bias, Egger's test was used. If a significant publication bias was found, the fail-safe N and trim-fill tests were performed to confirm the degree of publication bias. A *p*-value \<0.05 was considered significant.

3. Results {#sec3-jcm-09-01484}
==========

3.1. Selection and Characteristics of Studies {#sec3dot1-jcm-09-01484}
---------------------------------------------

A total of 478 studies were identified in the database searching for the meta-analysis. Finally, 51 studies were selected according to the inclusion and exclusion criteria. Among the searched studies, 184 studies were excluded due to a lack of sufficient information. In addition, 160 reports were excluded due to being non-original articles. Other remaining reports were excluded for the following reasons: focusing on other diseases (*n* = 52), articles in a language other than English (*n* = 29), and duplicate articles (*n* = 2) ([Figure 1](#jcm-09-01484-f001){ref-type="fig"}). The characteristics of the eligible studies are shown in [Table 1](#jcm-09-01484-t001){ref-type="table"}.

3.2. The Incidence Rate of IGBC after Cholecystectomy {#sec3dot2-jcm-09-01484}
-----------------------------------------------------

The incidence rate of IGBC after cholecystectomy was 0.6% (95% confidence interval (CI) 0.5--0.8%) in overall patients ([Table 2](#jcm-09-01484-t002){ref-type="table"}). The incidence rate of IGBC after laparoscopic cholecystectomy was 0.7% (95% CI 0.5--0.9%). The incidence rate of the subgroup using the patients' registry was significantly lower than that of subgroup using individual hospital data (0.2% vs. 0.7%; *p* = 0.002 in the meta-regression test). However, there were no significant differences of incidence rates between study years.

Next, the patients' age and sex of IGBC were investigated and compared with overall GBC. Patients with IGBC had a significantly older age than the overall patients (*p* \< 0.001 in meta-regression test). The patients' age of IGBC and overall GBC were 65.291 (95% CI 63.867--66.715) and 52.023 (95% CI 49.208--54.839), respectively ([Table 3](#jcm-09-01484-t003){ref-type="table"}). The female ratio of IGBC was 69.4% (95% CI 66.0--72.7%). There was no significant difference of female ratio between IBC and overall GBC (*p* = 0.817 in the meta-regression test). The age and female ratio was higher in the subgroup using the registry than in the subgroup using the individual hospital data. The IGBC showed the highest rate in the pT2 stage than in other pT stages ([Table 4](#jcm-09-01484-t004){ref-type="table"}). The estimated rates of IGBC were 13.0% (95% CI 7.9--20.6%), 34.1% (95% CI 28.3--40.3%), 39.7% (95% CI 34.8--44.8%), 22.7% (95% CI 19.5--26.4%), and 12.5% (95% CI 7.3--20.6%) in the pTis, pT1, pT2, pT3, and pT4 stages, respectively.

3.3. Comparison of Prognosis between IGBC and Non-IGBC {#sec3dot3-jcm-09-01484}
------------------------------------------------------

The prognosis of IGBC was evaluated by comparing it to non-IGBC. Patients with IGBC had a better overall survival rate than patients with non-IGBC (HR 0.574, 95% CI 0.445--0.739; [Figure 2](#jcm-09-01484-f002){ref-type="fig"}). However, there was no significant difference of the disease-free survival rate between patients with IGBC and non-IGBC (HR 0.931, 95% CI 0.618--1.402).

4. Discussion {#sec4-jcm-09-01484}
=============

To the best of our knowledge, the present study is the first meta-analysis to investigate the incidence rate of IGBC and to compare the prognosis of IGBC and non-IGBC patients. Previous studies, including systematic reviews and meta-analyses, have reported IGBC after cholecystectomy. The previous meta-analysis showed the incidence rate and the prevalence of pT stage of IGBC using 26 eligible studies \[[@B59-jcm-09-01484]\]. However, the information for the prognosis of IGBC cannot be obtained in the previous meta-analysis. We also analyzed the incidence rates according to the type of surgery and study and the patients' age and sex.

Eligible studies of the current meta-analysis showed the information for the combined group with laparoscopic and open cholecystectomy or laparoscopic cholecystectomy alone. Among the eligible studies, data for the incidence of IGBC after open cholecystectomy could not be obtained. In daily practice, laparoscopic cholecystectomy is a gold standard for benign diseases of GB rather than open cholecystectomy. However, the comparison of the incidence rate of IGBC between laparoscopic and open cholecystectomies could not be performed due to no information for open cholecystectomy.

We indirectly compared the incidence rates between patients with laparoscopic cholecystectomy and overall patients. The estimated incidence rates of IGBC were 0.7% and 0.6% in patients with laparoscopic cholecystectomy and overall patients, respectively. The incidence rates ranged from 0.1% to 2.9% in the eligible studies. Eligible studies obtained the information from a single individual hospital or public registry. The estimated incidence rate of the single individual hospital was significantly higher than that of the public registry (0.7% vs. 0.2%). This discrepancy may be caused by the size of the population and different hospitals. In addition, because single individual hospital data may be obtained from tertiary hospitals or training hospital, the ratio of elective cholecystectomy with benign diseases can be lowered.

Unlike the previous meta-analysis, we performed the meta-analysis for the overall and disease-free survival rates of IGBC compared to non-IGBC. However, the information for the disease-free survival rate was only shown in one study \[[@B48-jcm-09-01484]\]. As this study showed the disease-free survival rates divided into pT2 and pT3 stages, the meta-analysis could be performed. However, there was no significant difference of the disease-free survival between patients with IGBC and non-IGBC. In the comparison of overall survival rates, patients with IGBC had a favorable prognosis compared to patients with non-IGBC. However, among eligible studies, some studies demonstrated no significant difference of overall survival rates \[[@B12-jcm-09-01484],[@B51-jcm-09-01484]\].

This difference of prognosis between IGBC and non-IGBC may be caused by the difference of the tumor stage at the initial diagnosis (pT stage) in IGBC than in non-IGBC. In the current meta-analysis, IGBCs were detected from pTis to pT4. The highest rate of pT stage was the pT2 stage in IGBC (39.7%, 95% CI 34.8--44.8%). In the current study, patients with IGBC were frequently confirmed to pTis to pT2 stages. The pT3 and pT4 stages were 22.7% and 12.5%, respectively. However, the previous meta-analysis reported that the pT4 stage rate of IGBC was 4.2% (Choi KS 2015). In addition, patients with a lower pT stage had better survival rates than those with a higher pT stage, regardless of preoperative suspicion \[[@B12-jcm-09-01484],[@B33-jcm-09-01484]\]. Thus, the lower pT stage of IGBC may impact the better prognosis of IGBC compared to non-IGBC. Further evaluation for the prognosis of IGBC and non-IGBC will be needed based on the stratification of pT stage. As the extent of pathologic examination can impact the pT stage, further evaluations are needed.

A previous study reported that the preoperative nonsuspicious cases were 50--70% of the overall GBCs \[[@B54-jcm-09-01484],[@B60-jcm-09-01484]\]. For the detection of GBC in the postoperative pathologic examination, the appropriate sections are needed for the suspicious lesion. However, in daily practice, because all portions of GB cannot be evaluated in the microscopic examination, the careful macroscopic examination from expert pathologists may be important. Previous studies suggested the effect of frozen sections on the detection of IGBC \[[@B4-jcm-09-01484],[@B36-jcm-09-01484]\].

The intraoperative detection of IGBC with pT2 or higher stages via frozen sections can be useful for the prompt conversion of radical surgery \[[@B47-jcm-09-01484]\]. The rates of pTis and pT1 stages were 13.0% and 34.1%, and the frozen section was not useful for non-mass-forming GBC. Therefore, in pT2 and higher stages, the intraoperative frozen may be useful for infiltrative lesions into the adjacent tissue. Nitta et al. \[[@B36-jcm-09-01484]\] suggested that the examination for the full thickness of the gallbladder through the frozen section could be useful for the detection of IGBC and differentiation between pTis/T1a and others. The most common macroscopic feature is the wall thickening of GBC. As there are limitations on the extent and time of examination of frozen sections, the impact on the detection of IGBC is limited. Frozen sections can be useful for suspicious lesions detected by surgeons \[[@B4-jcm-09-01484]\].

Some limitations in the current meta-analysis exist. First, in this meta-analysis, the pN stage and nodal disease were not analyzed. Laparoscopic cholecystectomy is enough for treatment for IGBC with the pTis to pT1 stage. Therefore, lymph node dissection could not be performed in many cases with IGBC. Second, by definition, missing cases in the preoperative radiologic examination should be considered for non-IGBC. However, the detailed information for preoperative radiologic findings could not be found in the eligible studies. Based on this limitation, the incidence rate of IGBC may be lower. Third, the present study was not performed for the subgroup analysis for tumor types, such as lymphoma and squamous cell carcinoma, due to the very low incidence of other tumor types. Fourth, the detailed comparisons between IGBC and benign diseases could not be performed due to insufficient information on eligible studies. However, IGBC frequently occurred with older age and male subjects, compared to benign diseases. Fifth, the impact of histologic examination on the detection rate of IGBC could not be investigated due to insufficient information of the examined section or extent. Sixth, the impact of pT stages of IGBC on survival rates could not be obtained due to insufficient information. Seventh, subgroup analysis based on the types of benign diseases, such as acute/chronic cholecystitis, could not be obtained due to insufficient information.

5. Conclusions {#sec5-jcm-09-01484}
==============

In conclusion, IGBC was found in 0.6% of cholecystectomy with benign diseases. IGBCs had higher rates in the pT1 and pT2 stages and frequently occurred in older patients. In addition, patients with IGBCs had a better prognosis than those with non-IGBCs. To detect IGBC after cholecystectomy, a sufficient examination for histology is needed in the pathologic examination.
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jcm-09-01484-t001_Table 1

###### 

Main characteristics of the eligible studies.

  ------------------------------------------------------------------------------------------------------------------------------------
  First Author, Year   Location        Study Year   Using\     Initial\   No of Patients   Tumor Stage                            
                                                    Registry   Surgery                                                            
  -------------------- --------------- ------------ ---------- ---------- ---------------- ------------- ---- ---- ---- ---- ---- ----
  Ahn 2016             Korea           1998−2014               ND         4629             73                                     

  Aoki 2002            Japan           1990−1999               LC         990              11                 5         6         

  Apodaca-Rueda 2017   Brazil          2010−2015               ND         893              13                                     

  Basak 2016           Turkey          2009−2013               LC/Open    1747             4                            3    1    

  Braghetto 1999       Chile           1992−1998               LC         6500             15                      4    5    6    

  Cavallaro 2012       Italy           1998−2008               LC         1480             9                  1    4    4         

  Chan 2003            Taiwan          1992−2000               LC         1825             11                      3    4    3    1

  Charfi 2018          Tunisia         2003−2016               LC/Open    20,584           155                     18   68   36   33

  Choi 2009            Korea           2002−2007               LC         3145             33                      12   17   4    

  Cziupka 2012         Germany         2001−2009               ND         ND               12                      3    5    3    1

  D'Hondt 2013         Belgium         1998−2008               LC/Open    ND               45                                     

  Dorobisz 2016        Poland          1990−2014               LC/Open    7314             64                                     

  Duzkoylu 2015        Turkey          2005−2013               LC         8698             15                 3    2    5    3    

  Ferrarese 2013       Italy           2008−2012               LC         508              7                            5    2    

  Firat 2019           Turkey          2015−2017               LC/Open    1112             7                  1    3    3         

  Genc 2011            Turkey          1999−2010               LC         5164             5                  1    1    1    2    

  Geramizadeh 2018     Iran            2010−2016               LC/Open    4872             18                      10   8         

  Glauser 2011         Switzerland     ND           Yes        LC/Open    30,960           69                 2    14   34   14   5

  Goussous 2018        USA             2000−2013               LC/Open    5796             26                                     

  Gulwani 2015         India           2001−2013               LC         2926             23                      5    14   4    

  Horkoff 2019         Canada          2001−2015    Yes        LC/Open    11,4951          129                                    

  Ioannidis 2013       Greece          1992−2001               LC/Open    1536             14                      5    6    3    

  Jha2018              India           2014−2016               LC/Open    4800             20                      18   2         

  Kalita 2013          India           2009−2012               LC/Open    4107             18                 1    7    10        

  Kim 2010             Korea           1997−2008               LC/Open    2607             26                 1    6    17   2    

  Koppatz 2018         Finland         2010−2012               LC/Open    2034             10                                     

  Kwon 1997            Korea           1990−1996               ND         527              10                      5    3    2    

  Kwon 2008            Japan           1992−2004               LC         1793             38                      20   17   1    

  Lundgren 2018        Sweden          2007−2014    Yes        LC/Open    36,010           213           23   14   41   72   51   12

  Martins-Filho 2015   Brazil          2007−2010               LC/Open    2018             10                                     

  Mazer 2012           USA             1984−2008               ND         ND               443                                    

  Mitrovic 2010        Bosnia et al.   ND                      LC/Open    3007             21                                     

  Mori 1997            Japan           1991−1995               LC         456              13                      9    3    1    

  Nitta 2018           Japan           2009−2017               LC/Open    529              8                  2    1    3    2    

  Panebianco 2013      Italy           2003−2011               LC         1188             6                       1    2    3    

  Patel 2016           UK              2008−2013               LC/Open    4027             7                  1    2    2    2    

  Pitt 2014            USA             2005−2009    Yes        LC/Open    91,260           170                                    

  Sarli 2000           Italy           1992−1999               LC/Open    2300             20                 1    6    4    9    

  Shimizu 2006         Japan           1991−2004               LC         1195             10                      4    5    1    

  Solaini 2014         UK              2005−2012               LC/Open    864              7                                      

  Talreja 2016         Pakistan        2005−2015               LC         964              11                 1    4    6         

  Tantia 2009          India           2004−2007               LC         3205             19                 8    8    3         

  Tatli 2017           Italy           2013−2016               LC/Open    341              7                       3    4         

  Tian 2015            China           2002−2012               LC         7582             69                      22   16   13   18

  Utsumi 2017          Japan           2008−2015               LC         352              8                       3    4    1    

  Vega 2019            USA             1999−2016               ND         ND               11                                     

  Xu 2013              China           1993−2011               LC         8005             36                      16   11   9    

  Yamamoto 2005        Japan           1991−2003               LC         1663             9                  1    3    5         

  Yi 2013              China           1992−2009               LC/Open    14073            38                      14   4    13   7

  Zhang 2015           China           1999−2007               LC         11574            28                 4    9    8    5    2

  Zhu 2015             China           2000−2010               LC         4014             29                      11   14   4    
  ------------------------------------------------------------------------------------------------------------------------------------

No, number; IGBC, incidental gallbladder cancer; Tis, in situ; ND, no description; LC, laparoscopic cholecystectomy.

jcm-09-01484-t002_Table 2

###### 

The estimated rates of incidental gallbladder cancer after cholecystectomy.

  ------------------------------------------------------------------------------------------------------------------------------------------
  Subgroup          Number of Subsets   Fixed Effect\            Heterogeneity Test (*p*-Value)   Random Effect \[95% CI\]   Egger's Test\
                                        \[95% CI\]                                                                           (*p*-Value)
  ----------------- ------------------- ------------------------ -------------------------------- -------------------------- ---------------
  Overall           47                  0.005 \[0.005, 0.005\]   \<0.001                          0.006 \[0.005, 0.008\]     0.070

  Laparoscopic      21                  0.007 \[0.007, 0.008\]   \<0.001                          0.007 \[0.005, 0.009\]     0.517

  Using registry    4                   0.003 \[0.002, 0.003\]   \<0.001                          0.002 \[0.001, 0.005\]     0.499

  Individual        43                  0.007 \[0.007, 0.008\]   \<0.001                          0.007 \[0.006, 0.008\]     0.294

  Included 1990's   19                  0.007 \[0.006, 0.007\]   \<0.001                          0.007 \[0.004, 0.010\]     0.972

  Included 2000's   21                  0.004 \[0.004, 0.004\]   \<0.001                          0.006 \[0.004, 0.008\]     0.253

  after 2010 year   6                   0.006 \[0.005, 0.008\]   \<0.001                          0.007 \[0.004, 0.012\]     0.198
  ------------------------------------------------------------------------------------------------------------------------------------------

CI, Confidence interval.

jcm-09-01484-t003_Table 3

###### 

Comparisons of age and female ratio between incidental and non-incidental gallbladder cancers.

  Subgroup         Number of Subsets   Fixed Effect \[95% CI\]     Heterogeneity Test (*p*-Value)   Random Effect \[95% CI\]    Egger's Test (*p*-Value)
  ---------------- ------------------- --------------------------- -------------------------------- --------------------------- --------------------------
  Age                                                                                                                           
  IGBC             41                  70.239 \[69.945, 70.534\]   \<0.001                          65.291 \[63.867, 66.715\]   \<0.001
  Laparoscopic     19                  69.234 \[68.703, 69.765\]   \<0.001                          64.179 \[61.280, 67.077\]   \<0.001
  Using registry   3                   71.613 \[71.208, 72.017\]   0.083                            71.149 \[69.890, 72.408\]   0.524
  Individual       38                  68.695 \[68.265, 69.124\]   \<0.001                          64.629 \[62.801, 66.458\]   \<0.001
  Overall          17                  49.797 \[49.770, 49.824\]   \<0.001                          52.023 \[49.208, 54.839\]   0.199
  Laparoscopic     4                   48.289 \[48.048, 48.529\]   \<0.001                          49.014 \[43.925, 54.103\]   0.938
  Individual       17                  49.797 \[49.770, 49.824\]   \<0.001                          52.023 \[49.208, 54.839\]   0.199
  Female ratio                                                                                                                  
  IGBC             41                  0.695 \[0.668, 0.721\]      0.113                            0.694 \[0.660, 0.727\]      0.980
  Laparoscopic     19                  0.658 \[0.607, 0.705\]      0.671                            0.658 \[0.607, 0.705\]      0.333
  Using registry   3                   0.735 \[0.691, 0.775\]      0.001                            0.761 \[0.628, 0.857\]      0.588
  Individual       38                  0.673 \[0.638, 0.706\]      0.744                            0.673 \[0.638, 0.706\]      0.147
  Overall          23                  0.683 \[0.681, 0.685\]      \<0.001                          0.689 \[0.659, 0.717\]      0.891
  Laparoscopic     6                   0.661 \[0.652, 0.669\]      \<0.001                          0.635 \[0.584, 0.683\]      0.187
  Individual       23                  0.683 \[0.681, 0.685\]      \<0.001                          0.689 \[0.659, 0.717\]      0.891

CI, Confidence interval; IGBC, incidental gallbladder cancer.

jcm-09-01484-t004_Table 4

###### 

The estimated rates of tumor stages of incidental gallbladder cancer after cholecystectomy.

  Subgroup      Number of Subsets   Fixed Effect \[95% CI\]   Heterogeneity Test (*p*-Value)   Random Effect \[95% CI\]   Egger's Test (*p*-Value)
  ------------- ------------------- ------------------------- -------------------------------- -------------------------- --------------------------
  Tumor stage                                                                                                             
  pTis          17                  0.125 \[0.094, 0.163\]    0.002                            0.130 \[0.079, 0.206\]     0.853
  pT1           34                  0.300 \[0.270, 0.331\]    \<0.001                          0.341 \[0.283, 0.403\]     0.022
  pT2           37                  0.395 \[0.364, 0.426\]    0.001                            0.397 \[0.348, 0.448\]     0.957
  pT3           27                  0.230 \[0.203, 0.260\]    0.253                            0.227 \[0.195, 0.264\]     0.311
  pT4           8                   0.156 \[0.126, 0.191\]    \<0.001                          0.125 \[0.073, 0.206\]     0.255

CI, Confidence interval.
